[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Evolus Inc (EOLS)

Evolus Inc (EOLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Evolus Inc 520 Newport Center Dr. Suite 1200 Newport Beach CA 92660 USA

www.evolus.com Employees: 334 P: 949-284-4555

Sector:

Medical

Description:

Evolus, Inc. is a medical aesthetics company. It focuses on providing physicians and patients in aesthetic procedures and treatments. The company focuses on the self-pay aesthetic market and its lead product candidate, DWP-450, is an injectable 900 kDa purified botulinum toxin type A complex. Evolus, Inc. is based in Irvine, California.

Key Statistics

Overview:

Market Capitalization, $K 344,818
Enterprise Value, $K 437,088
Shares Outstanding, K 65,060
Float, K 61,221
% Float 94.10%
Short Interest, K 6,517
Short Float 10.02%
Days to Cover 6.57
Short Volume Ratio 0.60
% of Insider Shareholders 5.90%
% of Institutional Shareholders 90.69%

Financials:

Annual Sales, $ 297,180 K
Annual Net Income, $ -51,640 K
Last Quarter Sales, $ 90,300 K
Last Quarter Net Income, $ 130 K
EBIT, $ -28,320 K
EBITDA, $ -18,290 K

Growth:

1-Year Return -54.11%
3-Year Return -39.36%
5-Year Return -41.82%
5-Year Revenue Growth 425.61%
5-Year Earnings Growth 64.76%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.06 on 03/03/26
Next Earnings Date 05/04/26 [AMC]
Earnings Per Share ttm -0.75
EPS Growth vs. Prev Qtr 100.00%
EPS Growth vs. Prev Year 100.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

EOLS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -21.57%
Profit Margin % -17.38%
Debt/Equity -6.32
Price/Sales 1.16
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.36
Interest Coverage -1.59
60-Month Beta 1.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.